Recap: Oncternal Therapeutics Q4 Earnings
Recap: Oncternal Therapeutics Q4 Earnings
Oncternal Therapeutics (NASDAQ:ONCT) reported its Q4 earnings results on Thursday, March 7, 2024 at 04:01 PM.
Oncternal Therapeutics（納斯達克股票代碼：ONCT）於2024年3月7日星期四下午4點01分公佈了其第四季度業績。
Here's what investors need to know about the announcement.
以下是投資者需要了解的有關該公告的信息。
Earnings
收益
Oncternal Therapeutics missed estimated earnings by -1.0%, reporting an EPS of $-3.11 versus an estimate of $-3.07.
Oncternal Therapeutics報告的每股收益爲-3.11美元，未達到預期的-1.0％，而預期的收益爲-3.07美元。
Revenue was up $126 thousand from the same period last year.
收入比去年同期增長了12.6萬美元。
Past Earnings Performance
過去的收益表現
Last quarter the company missed on EPS by $0.6 which was followed by a 3.0% drop in the share price the next day.
上個季度，該公司的每股收益下跌了0.6美元，隨後第二天股價下跌了3.0％。
Here's a look at Oncternal Therapeutics's past performance:
以下是Oncternal Therapeutics過去的表現：
| Quarter | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 |
|---|---|---|---|---|
| EPS Estimate | -2.8 | -3.2 | -4 | -4.2 |
| EPS Actual | -3.4 | -3 | -4 | -4 |
| Revenue Estimate | 120K | 200K | 170K | 330K |
| Revenue Actual | 179K | 106K | 203K | 171K |
| 季度 | 2023 年第三季度 | 2023 年第二季度 | 2023年第一季度 | 2022 年第四季度 |
|---|---|---|---|---|
| 每股收益估算 | -2.8 | -3.2 | -4 | -4.2 |
| 實際每股收益 | -3.4 | -3 | -4 | -4 |
| 收入估算 | 120K | 200 | 170K | 330K |
| 實際收入 | 179K | 106K | 203K | 171K |
To track all earnings releases for Oncternal Therapeutics visit their earnings calendar here.
要追蹤Oncternal Therapeutics發佈的所有業績，請在此處訪問他們的業績日曆。
This article was generated by Benzinga's automated content engine and reviewed by an editor.
本文由Benzinga的自動內容引擎生成，並由編輯審閱。